(VIANEWS) – NAVAMEDIC (NAVA.OL), VOLUE (VOLUE.OL), WILH. WILHELMSEN A (WWI.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NAVAMEDIC (NAVA.OL)
22.8% sales growth and 22.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.73.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 21.62. Meaning, the purchaser of the share is investing kr21.62 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Sales Growth
NAVAMEDIC’s sales growth is 11.5% for the current quarter and 22.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 93.3%, now sitting on 440.93M for the twelve trailing months.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr37.40 at 02:20 EST, way under its 52-week high of kr43.60 and way above its 52-week low of kr27.80.
More news about NAVAMEDIC.
2. VOLUE (VOLUE.OL)
17.4% sales growth and 3.91% return on equity
Volue ASA, together with its subsidiaries, engages in the provision of software and technology solutions for the energy, power grid, and infrastructure markets worldwide. It operates in three segments: Energy, Power Grid, and Infrastructure. The Energy segment offers software solutions and consulting services related to forecasting and optimization of the different energy markets that enables end-to-end optimization of the green energy value-chain. The Power Grid segment provides software solutions and consulting services that enables power distributors to support electrification of society by unlocking flexibility and digital management of the power grid. The Infrastructure segment offers software solutions and consulting services that delivers flexible solutions for digital water management. This segment is also involved in the automation of processes and machines for the construction industry. Volue ASA was incorporated in 2019 and is headquartered in Oslo, Norway. Volue ASA operates as a subsidiary of Arendals Fossekompani ASA.
Earnings Per Share
As for profitability, VOLUE has a trailing twelve months EPS of kr0.22.
PE Ratio
VOLUE has a trailing twelve months price to earnings ratio of 96.82. Meaning, the purchaser of the share is investing kr96.82 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.91%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.7%, now sitting on 1.27B for the twelve trailing months.
More news about VOLUE.
3. WILH. WILHELMSEN A (WWI.OL)
16.9% sales growth and 7.53% return on equity
Wilh. Wilhelmsen Holding ASA provides maritime products and services in Europe, the Oceania, Asia and Africa, and the Americas. It operates through three segments: Maritime Services, New Energy, and Strategic Holdings and Investments. The company offers marine products, including Nalfleet water treatment products to treat and protect on board systems; Unitor chemicals and equipment to clean vessels; Unicool refrigerants; Timm ropes for the maritime industry; Unitor fuel treatment chemicals; Unitor equipment for the maintenance and performance vessels; Unitor cylinders; marine specialty lubricants; and Unitor oil spill equipment and products, and sorbents and booms. It also provides ship agency services to the merchant fleet, as well as ship management services, including manning for various vessels. The company also engages in the operation of supply bases for the offshore industry; development and operation of real estate properties on and off the supply bases; and maintenance of rigs and handling of logistics related to international pipeline projects and windmill parks. Further, it offers technical and crew management services for the offshore wind market, and digital solutions for the shipping industry. Wilh. Wilhelmsen Holding ASA also provides marine and non-marine insurance services; and investment, port, and infrastructure and supply solutions. The company was founded in 1861 and is headquartered in Lysaker, Norway. Wilh. Wilhelmsen Holding ASA is a subsidiary of Tallyman AS.
Earnings Per Share
As for profitability, WILH. WILHELMSEN A has a trailing twelve months EPS of kr51.77.
PE Ratio
WILH. WILHELMSEN A has a trailing twelve months price to earnings ratio of 5.24. Meaning, the purchaser of the share is investing kr5.24 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.53%.
Volume
Today’s last reported volume for WILH. WILHELMSEN A is 1027 which is 89.54% below its average volume of 9823.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 6 and the estimated forward annual dividend yield is 2.17%.
More news about WILH. WILHELMSEN A.
4. TIPIAK (TIPI.PA)
13.7% sales growth and 6.82% return on equity
Tipiak Société Anonyme, a food company, manufactures prepared food products, frozen ready-meals, pastry products, groceries, and crusty bread products. The company offers groceries, such as breadcrumbs, cereals, couscous, croutons, Japanese pearls, potato starch, quinoa, and tapioca; frozen products, including savory products, appetizers, and side dishes with grains; and frozen sweet products comprising macarons, mini eclairs, and petits fours. It sells its products in France, England, and the United States. The company was founded in 1830 and is based in Saint-Aignan-Grandlieu, France.
Earnings Per Share
As for profitability, TIPIAK has a trailing twelve months EPS of €4.62.
PE Ratio
TIPIAK has a trailing twelve months price to earnings ratio of 12.55. Meaning, the purchaser of the share is investing €12.55 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.82%.
Yearly Top and Bottom Value
TIPIAK’s stock is valued at €58.00 at 02:20 EST, way under its 52-week high of €70.00 and way above its 52-week low of €49.60.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.9%, now sitting on 239.37M for the twelve trailing months.
More news about TIPIAK.
